Good morning, everyone. My name is Dina Elmonshed, one of the U.S. biotech analysts here at UBS. And joining me today is the President and CEO of Vertex Pharmaceuticals, Reshma Kewalramani. Thank you ...
Sound Off is an opinion forum for Mercury readers to offer brief comments on today’s news. Submissions must be 75 words or fewer and are subject to editing for grammar and clarity. Publication is at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback